Cowen analyst Joshua Jennings remains positive about Medtron...
Cowen analyst Joshua Jennings remains positive about Medtronic's growth, despite recent revenue downgrades. The company's earnings results saw only one downward revision and 17 upward revisions.
Medtronic Q3 in Focus Amid MedTech's Post-COVID Gains
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3169Followers
0Following
7919Visitors
Follow